Looks like you clickedhttps://www.urotoday.com/conference-highlights/esmo-2023/esmo-2023-prostate-cancer/147470-esmo-2023-phase-1-2-trial-of-oral-epi-7386-in-combination-with-enzalutamide-compared-to-enzalutamide-alone-in-mcrpc-subjects-current-phase-1-results.html
If you do not want to visit that page, you can close this browser tab.
